Avanos Medical, Inc.

AVNSNYSEHealthcare● Active

$25.01

$-0.05(-0.18%)

Market Cap$1.2B

P/E Ratio—

52W High$25.49

52W Low$9.303

Avg Volume1.5M

Open$25.10

Beta1.57

Free Cash Flow Financials Revenue

Avanos Medical, Inc. (AVNS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

AVNS · free cash flow · updated Jun 8, 2026

Core FCF metrics

AVNS · FCF · TTM · margin & CAGR

Free cash flow was $43.1M for FY2025 (fiscal year ending 2025-12-31), down 48.0% year-over-year The FCF margin was 6.2%.

FY2025 Free Cash Flow$43.1M▼ -48.0% YoY

Trailing 12M (TTM)$7.5Mtrailing 4 quarters sum

FCF Margin6.2%$43.1M ÷ revenue

3-Year CAGR-15.6%FY2022 → FY2025

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

AVNS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$74.7M(32M)$43.1M▼ 48.0%6.2%

FY2024$100.7M(18M)$82.9M▲ +467.8%12.1%

FY2023$32.4M(18M)$14.6M▼ 79.6%2.2%

FY2022$90.9M(19M)$71.6M▲ +8.0%10.5%

FY2021$87.3M(21M)$66.3M▲ +392.1%8.9%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

AVNS · P/FCF · FCF yield · FCF per share

Avanos Medical, Inc. (AVNS) trades at a FCF yield of 0.64% and a price-to-free-cash-flow ratio of 156.3x. FCF per share stands at $0.16, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

0.64%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.16

TTM FCF ÷ Shares Outstanding

Price / FCF

x156.3

Share Price ÷ FCF per Share

EV / FCF (TTM)

x166.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

AVNS · cash flow statement · operating / investing / financing

For FY2025, Avanos Medical, Inc. generated $74.7M in operating cash flow and spent 32M in capital expenditures, yielding $43.1M in free cash flow.

Operating Activities

+$74.7M

Cash from core business operations

2025-12-31

Investing Activities

−$60.6M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$37.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($74.7M) − |CapEx| (32M) = FCF ($43.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

AVNS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Avanos Medical, Inc.YOU

AVNS

$43.1M-48.0%6.1%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Avanos Medical, Inc. (AVNS) reported free cash flow of $43.1M for FY2025 (fiscal year ending 2025-12-31), down 48.0% year-over-year. The FCF margin was 6.2%.

Based on available data, Avanos Medical, Inc. has maintained positive free cash flow for at least 12 fiscal year(s). FCF peaked at $174.8M in FY2013.

Avanos Medical, Inc.'s FCF yield is 0.64% and price-to-FCF ratio is 156.3x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

AVNS free cash flow · 8 questions

Avanos Medical, Inc. free cash flow was $43.1M for FY2025, down 48.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $7.5M.

AVNS free cash flowAVNS FCFAVNS FCF 2025AVNS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Avanos Medical, Inc. · Avanos Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026